Literature DB >> 16225866

Osmotic regulation of STAT3 stability in H4IIE rat hepatoma cells.

Mohammad Lornejad-Schäfer1, Ute Albrecht, Diana Poppek, Thor Gehrmann, Tilman Grune, Johannes G Bode, Dieter Häussinger, Freimut Schliess.   

Abstract

Little is known about the regulation of signal transducer and activator of transcription (STAT) stability. Here the osmolarity-dependence of STAT3 stability, ubiquitination, Tyr(705) phosphorylation, STAT3 transactivation and gamma-fibrinogen (gamma-FBG) expression was studied in hepatoma cells. Hyper-osmolarity accelerated STAT3 degradation which was prevented by proteasome inhibitors. Hypo-osmolarity stabilized STAT3, most likely due to a decrease in STAT3 ubiquitination. Accordingly, STAT3 Tyr(705) phosphorylation, alpha(2)-macroglobulin promoter activity and gamma-FBG expression were osmosensitive. Modulation of STAT3 stability may contribute to a hydration dependence of acute phase protein expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225866     DOI: 10.1016/j.febslet.2005.09.053

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program.

Authors:  Peter J Houghton; Raushan T Kurmasheva; Dmitry Lyalin; John M Maris; E Anders Kolb; Richard Gorlick; C Patrick Reynolds; Min H Kang; Stephen T Keir; Jianrong Wu; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2014-08-17       Impact factor: 3.167

2.  Oncogenic Ras-induced morphologic change is through MEK/ERK signaling pathway to downregulate Stat3 at a posttranslational level in NIH3T3 cells.

Authors:  Hsuan-Heng Yeh; Chin-Han Wu; Raghavaraju Giri; Ken Kato; Kimitoshi Kohno; Hiroto Izumi; Cheng-Yang Chou; Wu-Chou Su; Hsiao-Sheng Liu
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

3.  Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.

Authors:  Britta Stapel; Michael Kohlhaas; Melanie Ricke-Hoch; Arash Haghikia; Sergej Erschow; Juhani Knuuti; Johanna M U Silvola; Anne Roivainen; Antti Saraste; Alexander G Nickel; Jasmin A Saar; Irina Sieve; Stefan Pietzsch; Mirco Müller; Ivan Bogeski; Reinhard Kappl; Matti Jauhiainen; James T Thackeray; Michaela Scherr; Frank M Bengel; Christian Hagl; Igor Tudorache; Johann Bauersachs; Christoph Maack; Denise Hilfiker-Kleiner
Journal:  Eur Heart J       Date:  2017-02-01       Impact factor: 29.983

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.